Related Experiment Video

Updated: Aug 15, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Immunologic aspect of ovarian cancer and p53 as tumor antigen

H W Nijman1, A Lambeck, S H van der Burg

  • 1Dept. of Gynaecologic Oncology, Groningen University Medical Center. h.w.nijman@og.umcg.nl

Journal of Translational Medicine
|September 17, 2005
PubMed

Insights

Ovarian cancer remains a leading cause of cancer death in women, but understanding tumor-immune interactions and p53 tumor antigen roles offers new hope for immunotherapy treatments.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Ovarian cancer is a significant cause of cancer mortality in women.
  • While chemotherapy has improved survival, most patients still succumb to the disease.
  • Ovarian cancer patients mount notable immune responses against their tumors.

Purpose of the Study:

  • To review current knowledge on the interplay between ovarian cancer cells and the immune system.
  • To summarize the role of p53 as a tumor antigen and potential therapeutic target in ovarian cancer.

Main Methods:

  • Literature review of existing research on ovarian cancer immunology.
  • Analysis of the role of p53 as a tumor antigen.

Main Results:

  • Ovarian cancer patients exhibit specific immune responses against tumor cells.
  • p53 is identified as a relevant tumor antigen in ovarian cancer.

Conclusions:

  • Increased understanding of immune system interactions in ovarian cancer is crucial.
  • Immunotherapy holds significant promise for future ovarian cancer treatment strategies.

More Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.